Alkem Laboratories Ltd
Teriparatide (0.250mg/ml)
Gemfrac Injection is a man-made version of parathyroid hormone used to treat men and postmenopausal women who have severe osteoporosis with a high risk of fractures.
Injection
Gemfrac Injection is a synthetic form of a natural human hormone called parathyroid hormone (PTH). It works by increasing the number and activity of bone-forming cells (osteoblasts). This strengthens the bones and minimizes the risk of fractures.
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
Gemfrac Injection is a synthetic form of a natural human hormone called parathyroid hormone (PTH). It works by increasing the number and activity of bone-forming cells (osteoblasts). This strengthens the bones and minimizes the risk of fractures.
Gemfrac Injection should be injected every day under the skin (subcutaneous injection) of the thigh or abdomen. Do not take it for more than 2 years. You may have low blood pressure and dizziness during the initial few days. If you feel dizzy (light-headed) after injection, sit or lie down until you feel better. Tell your doctor immediately if you experience nausea, vomiting, constipation, low energy, or muscle weakness. These may be signs of high calcium levels in your blood. Tell your doctor if you are breastfeeding, pregnant, or plan to become pregnant.
No, Gemfrac Injection is not a steroid. It is used to treat osteoporosis caused by long-term use of steroids.
Gemfrac Injection should be taken for no longer than a 2-year course. It is important to inform the doctor if you have taken this medication before, as multiple treatments exceeding one year should not be repeated.
Gemfrac Injection must be kept in a refrigerator at a temperature of 2°C to 8°C. Avoid placing the injection pens near the ice compartment, as freezing could damage the medication and decrease its effectiveness. The medication can be used up to 28 days after the first injection if not empty. If the pen is not empty within 28 days, please discard it safely.
Gemfrac Injection may not be suitable for patients with kidney impairment, Paget's disease, bone cancer, or high serum calcium levels. It is also advisable to avoid Gemfrac Injection in children, young adults and growing age, pregnant or lactating women. Always consult the doctor before starting medication, as this can help them determine the best course of treatment for you.